1. Home
  2. ESTA vs NKTR Comparison

ESTA vs NKTR Comparison

Compare ESTA & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Establishment Labs Holdings Inc.

ESTA

Establishment Labs Holdings Inc.

HOLD

Current Price

$93.11

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$70.53

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESTA
NKTR
Founded
2004
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
ESTA
NKTR
Price
$93.11
$70.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$86.86
$146.67
AVG Volume (30 Days)
682.5K
1.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
42.67
N/A
EPS
N/A
N/A
Revenue
$61,208,000.00
$307,711,000.00
Revenue This Year
$28.05
N/A
Revenue Next Year
$26.21
N/A
P/E Ratio
N/A
N/A
Revenue Growth
76.49
86.00
52 Week Low
$33.35
$21.02
52 Week High
$96.99
$109.00

Technical Indicators

Market Signals
Indicator
ESTA
NKTR
Relative Strength Index (RSI) 60.16 54.99
Support Level $63.71 $64.30
Resistance Level $92.84 $76.78
Average True Range (ATR) 3.57 3.47
MACD -0.25 0.04
Stochastic Oscillator 66.63 47.61

Price Performance

Historical Comparison
ESTA
NKTR

About ESTA Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: